MB
MPM BioImpact’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
395,700
-2,745
| -0.7% | -$99.8K | 2.49% | 16 |
|
|
2025
Q1 | $14.4M | Buy |
398,445
+7,427
| +2% | +$269K | 2.48% | 16 |
|
|
2024
Q4 | $16.5M | Buy |
391,018
+61,285
| +19% | +$2.58M | 2.34% | 17 |
|
|
2024
Q3 | $18.3M | Sell |
329,733
-50,819
| -13% | -$2.82M | 2.75% | 11 |
|
|
2024
Q2 | $15.6M | Buy |
380,552
+134,962
| +55% | +$5.55M | 2.43% | 10 |
|
|
2024
Q1 | $11.5M | Buy |
+245,590
| New | +$11.5M | 1.84% | 19 |
|